MYC and colorectal carcinoma: reported that knockdown of c-MYC substantially enhances the inhibitory effects of arenobufagin on the Nrf2 signaling pathway, as well as on CRC cell migration and invasion, highlighting the importance of disrupting the c-MYC/Nrf2 axis to mitigate lung metastasis (139).